Myasthenia gravis complement activity is independent of autoantibody titer and disease severity is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Myasthenia Gravis Foundation of America
Grant: High Impact Clinical Research and Scientific Pilot Project award
NINDS NIH HHS
Grant: U54 NS115054
Muscular Dystrophy Association
Grant: MDA575198
Grifols
Grant: SPIN award
Deutsche Forschungsgemeinschaft
Grant: DFG Research fellowship (FI 2471/1-1)
NIAID NIH HHS
Grant: R21 AI164590
National Institute of Allergy and Infectious Diseases
Grant: R01-AI114780
National Institute of Allergy and Infectious Diseases
Grant: R21-AI142198
NIAID NIH HHS
Grant: R01 AI114780
NIAID NIH HHS
Grant: R21 AI142198
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 5R01AI114780-04
Mechanisms of autoantibody production in myasthenia gravis
National Institutes of Health
Grant: 5R21AI142198-02
Novel Approaches for Investigating the Pathology of Myasthenia Gravis Autoantibodies
National Institutes of Health
Grant: 1R21AI164590-01
Molecular determinants driving diverse mechanisms of antibody-mediated pathology
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
UCB US
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals